Owlstone Medical secures $6.5 million to support development of breath-based diagnostics for infectious disease Post author: Post published:April 25, 2024 Post category:uncategorized Funding represents the first time the foundation has taken an equity position in a breath diagnostics company. You Might Also Like Successful treatment of metastatic malignant glomus tumor with BRAF and MEK inhibitors October 29, 2024 Study links high sugar intake to lower childhood asthma risk, while fat, magnesium, and vitamin D increase it May 27, 2024 Blooming health: Unfolding the petal-perfect virtues of edible flowers November 9, 2023
Successful treatment of metastatic malignant glomus tumor with BRAF and MEK inhibitors October 29, 2024
Study links high sugar intake to lower childhood asthma risk, while fat, magnesium, and vitamin D increase it May 27, 2024